Inarigivir
Inarigivir (ORI-9020) is a dinucleotide antiviral drug that can significantly reduce liver HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir (ORI-9020) act as a RIG-I agonist to activate cellular innate immune responses[1][2].
Product Specifications
CAS Number
475650-36-3
Product Name Alternative
ORI-9020; SB-9000
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Inarigivir.html
Purity
99.20
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
NC1=C(N=CN2[C@@H]3O[C@H](COP(O[C@H]4[C@@H](OC)[C@H](N5C=CC(NC5=O)=O)O[C@@H]4CO)(S)=O)[C@@H](O)C3)C2=NC=N1
Molecular Formula
C20H26N7O10PS
Molecular Weight
587.50
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SMO (Smoothened Homolog (Drosophila), Gx, SMOH) (MaxLight 550)
SMO (Smoothened Homolog (Drosophila), Gx, SMOH) (MaxLight 550)
